PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.\', \'Sorbonne Université, Paris, France.\', \'Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.\', \'Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.\', \'Cyprus International Institute for Environmental and Public Health, Cyprus University of Technology, Limassol, Cyprus.\', \'Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.\', \'Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.\', \'Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France fontanet@pasteur.fr.\', \'PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2020-045425
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 33795310
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
?:title
  • SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all